August 19, 2017, Myeloma Crowd Round Tables: Jackson, Mississippi


Register Now

Myeloma Crowd Round Tables are day-long meetings that provide patients and caregivers updated information so that they are able to make decisions about their treatment and care. Intended to go beyond “Myeloma 101” they help patients answer key questions: What should myeloma patients do at relapse? Or when they become refractory to treatments? Learn from top myeloma experts about relapsed and high-risk disease and what you can do to stay one step ahead for your best outcomes. This is a great opportunity to ask your questions and meet others in the myeloma community.

Topics will include:

  • Defining Standard and High-Risk Disease
  • Myeloma Genomics and How They Evolve During Treatment
  • Chromosomal Translocations and Deletions
  • Transplant Issues of Standard and High-Risk Disease
  • Monoclonal Antibodies and Immunotherapy
  • Strategies for Relapsed and Refractory Patients
  • Understanding and Choosing Clinical Trials

Date: August 19, 2017

Time: Registration begins at 8:30 am. Session runs from 9:30 am – 3:30 pm


  • Butler Snow Law Auditorium, 1020 Highland Colony Parkway, Ridgeland, MS
  • For hotel reservations, click here to contact the Hyatt Place Ridgeland for room reservations at the special rate of $119 per night
  • Closest airport is Jackson-Medgar Wiley Evers International Airport (JAN/KJAN)
  • Cost: Registration is $25 per person. (Please contact if you require additional financial assistance)


  • Gareth Morgan, MD, PhD, University of Arkansas Medical Sciences Myeloma Institute
  • Robert Orlowski, MD, PhD, MD Anderson Cancer Center
  • Noopur Raje, MD, Massachusetts General Hospital


Looking forward to seeing you in Jackson! 

Thanks to our sponsors: 




About Author

Jenny A

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical trials. Founder of Myeloma Crowd, Myeloma Crowd Radio and the CrowdCare Foundation.

Leave A Reply

Please enter the correct captcha code to verify that you are human.